Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
Apply
225Ac-ETN029, 111In-ETN029
Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step